Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Willis recommendations
Until that day comes, we will be here to help
Provide basic personal and insurance information as required
BPC-157 is a gastric pentadecapeptide that has been found to have positive effects on growth hormones and healing properties in various medical conditions such as spinal cord injury and burn wounds
The vote was taken twice: once for free base and once for acetate
The molecule was developed by the Australian pharmaceutical company Metabolic Pharmaceuticals (in collaboration with Monash University) and advanced through Phase I safety trials and a Phase IIb obesity efficacy trial enrolling approximately 900 participants in total
US$ 20.94
US$ 25.93
US$ 26.70
US$ 22.89
